Boyle Kevin S. Sr.'s Form 4 filing
Alaunos Therapeutics, Inc. (TCRT) · filed Sep 5, 2023
- Accession no.
- 0000950170-23-046504
- Filed
- Sep 5, 2023, 5:34 PM ET
- Trade date
- Sep 1, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $9.54K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Boyle Kevin S. Sr.CIK 0001880600 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2023 | Common Stock | SSaleDisposed | −68,014 | $0.1403 | −$9,542.36 | 798,236 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.